SLC6A4 and sudden infant death syndrome: Furthermore, sudden infant death syndrome has been associated with abnormal serotonin signaling such as: increased serum concentrations of serotonin (17), multiple brain serotonergic abnormalities (42, 43), and polymorphisms in the Sert promoter region (39).